ESTRO37_ProgrammeBook

Programme

>

Pre-meeting starts Eric Lartigau (FR)

08:30

08:30-09:30 >

SBRT today: for what? The clinically validated indications Matthias Guckenberger (CH) SBRT: the biology behind: only the dose effect? Franziska Eckert (DE)

>

09:30-10:30

>

Coffee break

10:30-11:00

>

Why combining systemic targeted or immuno therapy and high dose per fraction: local or systemic effects? Jean Bourhis (CH)

11:00-12:00

> Is immunotherapy a targeted therapy from the tumour point of view? Dirk De Ruysscher (NL)

12:00-13:00

>

Lunch

13:00-14:00

>

Clinical situations: Combining targeted/immunotherapy and high dose per fraction: lung Evert Van Limbergen (BE) Clinical situations: Combining targeted/immunotherapy and high dose per fraction: liver/gastrointestinal Mischa De Ridder (BE) Clinical situations: Combining targeted/immunotherapy and high dose per fraction: brain Stefan Nowicki (UK)

14:00-14:30

>

14:30-15:00

>

15:00-15:30

>

Coffee break

15:30-16:00

> What’s next: which combination in which studies to be planned? Eric Deutsch (FR )

16:00-17:00

> >

General debate

17:00 -17:30

Close of pre-meeting

17:30

Programme and Exhibition Guide | PROGRAMME

51